Q.1 Rabies (3+3 marks)

a) Categorize Animal Bite Exposures as per Latest WHO Guidelines

All Category II & III exposures require immediate wound treatment (soap + water wash for 15 min, then virucidal agent - povidone iodine/alcohol).

b) Current Schedule of Intra-Dermal Rabies Vaccination (IDRV) for Post-Exposure Prophylaxis

• Day 0: 0.1 mL ID at 2 sites
• Day 3: 0.1 mL ID at 2 sites
• Day 7: 0.1 mL ID at 2 sites
• Day 14: 0.1 mL ID at 2 sites (some schedules omit)
• Day 28/30: 0.1 mL ID at 1–2 sites (booster)

RIG (Rabies Immunoglobulin): For Category III - Human RIG (HRIG) 20 IU/kg body weight OR Equine RIG (ERIG) 40 IU/kg body weight, infiltrated at wound site on Day 0. Do not delay vaccine while waiting for RIG.

Q.2 HIV in 28-Year-Old Pregnant Woman (3+3 marks)

a) Describe Public Health Measures to Prevent Mother-to-Child Transmission (MTCT)

1. Universal HIV counselling and testing - Routine offer of HIV test to ALL pregnant women at ANC with "opt-out" approach; done at ICTCs
2. Lifelong ART for all HIV+ pregnant women - TDF + 3TC + EFV (triple drug regimen) regardless of CD4 count or WHO clinical stage (Option B+), both for maternal health and prevention of vertical transmission
3. Safe obstetric practices - Institutional deliveries; avoid unnecessary episiotomy, invasive monitoring, prolonged rupture of membranes
4. Infant prophylaxis - Nevirapine syrup given to the newborn for 6 weeks
5. Infant feeding counselling - Exclusive breastfeeding for 6 months while on ART OR replacement feeding if safe/affordable/feasible/sustainable/accessible (AFASS criteria)
6. Family-centric approach - Involve spouse/partner for testing; prevent re-infection
7. Co-infection management - Treat STIs, TB, and opportunistic infections
8. Nutritional and psychosocial support

b) Explain Role of National AIDS Control Programme in Management

• More than 15,000 ICTCs provide PPTCT services nationwide
• Frontline health workers (ANMs) conduct community-based HIV screening at sub-centre level
• ART centres provide free lifelong triple-drug ART
• HIV-exposed infants receive Early Infant Diagnosis (EID) via DNA-PCR at 6 weeks
• Linkage to care: HIV+ mother linked to ART centre; infant followed up at 18 months for confirmatory antibody testing
• Prevention of new infections through IEC/BCC campaigns, targeted interventions for high-risk groups

Q.3 30-Year-Old Man with >5 Hypo-Pigmented Patches (2+4 marks)

Diagnosis (2 marks)

• More than 5 hypo-pigmented (anaesthetic) skin patches - cardinal sign of leprosy
• Per WHO field criteria: >5 skin lesions = Multibacillary leprosy
• Confirm with: skin smear for AFB (positive in MB), skin biopsy

1. Hypo-pigmented/erythematous skin patches with loss of sensation
2. Thickened/enlarged peripheral nerves
3. Positive skin smear for AFB

Management as per National Leprosy Eradication Programme (4 marks)

• Provide pre-packed MDT blister packs free of charge under NLEP via PHC/CHC
• Disability assessment at start and end of treatment
• Lepra reaction management:
  • Type 1 (Reversal Reaction): Prednisolone 40-60 mg/day, continue MDT
  • Type 2 (ENL): Thalidomide / Prednisolone / Clofazimine, continue MDT
• Physiotherapy and self-care to prevent deformities
• Social rehabilitation, counselling to reduce stigma
• Contact examination of household contacts annually

Q.4 Short Notes (Any 3 out of 4) - (3×6=18 marks)

1. Disability-Adjusted Life Year (DALY)

DALY = YLL + YLD

• YLL (Years of Life Lost) = due to premature mortality
• YLD (Years Lived with Disability) = due to disability/morbidity

• YLL = N × L, where N = number of deaths and L = standard life expectancy at age of death
• YLD = I × DW × L, where I = incidence, DW = disability weight (0–1), L = average duration

1. Measures overall disease burden in a population
2. Compares burden of different diseases
3. Priority-setting for health interventions and resource allocation
4. Used in Cost-Effectiveness Analysis (CEA) as cost per DALY averted

2. Consequences of Failure to Disclose Medical Errors

• Continued harm from unrecognized/uncorrected error
• Loss of trust in the healthcare system
• Unable to make informed decisions about alternative treatment
• Denied legal recourse or compensation
• Psychological harm - anxiety, anger when truth later discovered

• Ethical violation (breaches principle of veracity/transparency)
• Increased risk of litigation (cover-up is legally far worse)
• Loss of professional credibility
• Psychological burden - guilt, moral injury, burnout
• License/disciplinary action if concealment discovered

• Errors not analyzed = errors repeat (no system learning)
• No quality improvement possible without error reporting
• Erosion of public trust in health institutions
• Increased healthcare costs from prolonged treatment of unresolved errors
• Undermines patient safety culture

3. Confounding Factor and Bias in Epidemiological Studies

1. Selection Bias - Systematic error in selecting study subjects (e.g., Berkson's bias, Neyman bias, Volunteer bias)
2. Information/Measurement Bias - Error in classifying exposure or outcome
   • Recall bias: Cases remember past exposure more than controls
   • Observer bias: Investigator's knowledge influences data collection
3. Confounding bias - (see below)

1. Must be associated with the exposure
2. Must be an independent risk factor for the disease
3. Must NOT be on the causal pathway between exposure and disease

• At design stage: Randomization, Matching, Restriction
• At analysis stage: Stratification (Mantel-Haenszel), Multivariate analysis, Standardization

4. Role of Family in Health and Disease (Describe with Suitable Examples)

• Healthy lifestyle habits (diet, exercise, hygiene) are shaped within the family
• Immunization decisions are family decisions
• Example: A family that maintains hand hygiene reduces diarrheal disease burden

• Genetic counseling and carrier detection (e.g., sickle cell, thalassemia)
• Early identification of symptoms and health-seeking behavior
• Example: Family history of diabetes prompts early screening in offspring

• Communicable diseases spread within families (TB, COVID-19, cholera)
• Genetic diseases cluster in families (hypertension, cancer)
• Behavioral risks - alcoholism, domestic violence, tobacco use
• Example: TB contact tracing is done within the family

• Family provides physical, emotional, and financial support during illness
• Adherence to treatment (e.g., DOTS supervision by family member)
• Example: Caregiver in the family critical for stroke rehabilitation

• Different stages (marriage, childbirth, aging) bring specific health challenges
• Family planning services target the family unit

5. 7×7 Strategy of Anaemia Mukt Bharat (AMB)

1. Children 6–59 months
2. Children 5–9 years
3. Adolescent girls and boys (10–19 years)
4. Pregnant women
5. Breastfeeding women
6. Women of reproductive age (15–49 years, non-pregnant, non-lactating)
7. Elderly (60+ years)

1. Prophylactic Iron and Folic Acid (IFA) supplementation - across life stages
2. Deworming - biannual deworming for children and adolescents
3. Intensified year-round IFA supplementation - using platform-based delivery (schools, AWCs)
4. Mandatory IFA fortification of rice - supplied through PDS/mid-day meal
5. Delayed cord clamping - at least 3 minutes at birth (for newborns)
6. Treatment of moderate/severe anaemia at health facilities
7. Behavioural change communication - to improve dietary diversification, address compliance issues

Definition of Family - as per K. Park's Textbook of Preventive and Social Medicine

Additional Elaboration Given by Park

Distinction: Family vs. Household

• Family = all members are blood relations (biologically related)
• Household = members may NOT be blood relations (e.g., servants living in the same house)

Two Types of Family (Sociological Terms)

1. Family of origin - the family into which one is born
2. Family of procreation - the family which one sets up after marriage

1. Define DALY
2. Differentiate control, elimination and eradication
3. Describe One Health approach
4. Isolation V/s Quarantine
5. Define herd immunity - give one suitable example
6. Mention 2 characteristics of a point source epidemic with a suitable diagram

Q.4 Very Short Answer (Any 5 out of 6) — 5×2=10 marks

1. Define Disability-Adjusted Life Year (DALY)

DALY = YLL + YLD

• YLL (Years of Life Lost) = No. of deaths at each age × expected remaining years of life (using a global standard life expectancy - Japanese life expectancy used as standard)
• YLD (Years Lived with Disability) = No. of incident cases × average duration of disease × disability weight (0 = perfect health; 1 = dead)

2. Differentiate Control, Elimination and Eradication

Elimination is an intermediate goal between control and eradication; it is now seen as an important precursor of eradication.

3. Describe the "One Health" Approach

• Human health
• Animal health (domestic + wildlife)
• Environmental/ecosystem health

• ~60% of human infectious diseases are zoonotic (arise from animals)
• Emerging infections (Ebola, Nipah, Avian flu, COVID-19) arise at the human-animal-environment interface
• Antimicrobial resistance (AMR) spans all three sectors

4. Isolation V/s Quarantine

5. Define Herd Immunity - Give One Suitable Example

"Herd immunity (or community immunity) describes a type of immunity that occurs when the vaccination of a portion of the population (or herd) provides protection to unprotected individuals."

1. Occurrence of clinical and subclinical infections in the herd
2. Immunization of the herd
3. Herd structure (births, deaths, population mobility)

6. Two Characteristics of a Point-Source Epidemic + Diagram

1. The epidemic curve rises and falls rapidly, with NO secondary waves - cases cluster within a narrow interval of time (explosive onset)
2. All cases develop within ONE incubation period of the disease from the time of exposure

Q.5 Structured Long Question (Any 1 out of 2) — 1×10=10 marks

Answer 1: Screening (2+4+4 marks)

Part A: Definition of Screening (2 marks)

"The search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy individuals." (Park's PSM)

• It is the active search for disease among apparently healthy people
• It is a presumptive identification of unrecognized disease - those who test positive are referred for confirmatory diagnostic tests and treatment
• It is NOT a diagnostic test; it is only an initial examination
• The initiative comes from the investigator/public health agency, not from the patient

Part B: Criteria for Selecting a Disease for Screening (4 marks)

1. Important health problem - The condition should be of significant public health importance (generally, high prevalence). Example: Diabetes mellitus, hypertension, cervical cancer.
2. Recognizable latent/early asymptomatic stage - There must be a detectable pre-symptomatic phase. Example: Carcinoma-in-situ (CIN) before invasive cervical cancer.
3. Adequately understood natural history - The progression from latent to declared disease must be known, so we can identify at which stage the process ceases to be reversible. Example: Natural history of cervical cancer is well understood over 10-15 years.
4. Detectable test available - There must be a test capable of detecting disease before signs and symptoms appear. Example: Pap smear for cervical cancer.
5. Facilities for confirmation - Diagnostic facilities must be available for those who screen positive.
6. Effective treatment available - Early treatment must genuinely reduce morbidity and mortality. There is no point in detecting a disease early if there is no treatment.
7. Agreed policy on whom to treat - Clear cut-off values or criteria for initiating treatment must exist. Example: BP >140/90 mmHg for hypertension, FBS >126 mg/dL for diabetes.
8. Evidence that early detection reduces morbidity/mortality - Good evidence that screening benefits patients. Example: Breast self-examination and mammography reduce breast cancer mortality.
9. Expected benefits exceed the risks and costs - Number of lives saved must justify the cost and any risks of the screening programme.

Only when ALL the above criteria are satisfied should a suitable screening test be selected.

Part C: Characteristics of an Ideal Screening Test (4 marks)

1. Acceptability

• The test must be acceptable to the population at whom it is aimed
• Tests that are painful, discomforting, or embarrassing (e.g., rectal/vaginal examinations) are not likely to achieve high participation in mass campaigns
• Example: Pap smear has low acceptability in rural Indian women

2. Repeatability (Reliability/Precision/Reproducibility)

• The test must give consistent results when repeated more than once on the same individual under the same conditions
• Affected by three factors:
  • Intra-observer variation - same observer, same subject, different readings
  • Inter-observer variation - two different observers, same subject
  • Biological/subject variation - natural fluctuation in the variable (e.g., BP varies)
• Example: Blood pressure measurement has poor repeatability due to all three factors

3. Validity (Accuracy)

• Sensitivity = TP / (TP + FN) × 100
• A highly sensitive test minimizes false negatives
• Example: A 90% sensitive test means 90% of diseased persons test positive

• Specificity = TN / (TN + FP) × 100
• A highly specific test minimizes false positives
• Sensitivity and specificity are inversely related
• An ideal test should be 100% sensitive AND 100% specific (rarely achieved in practice)

4. Yield

• The proportion of persons with previously unrecognized disease identified by the screening programme
• Determines the usefulness of the screening test in a given population

5. Simplicity

• The test should be simple to perform by paramedical personnel/technicians, without requiring extensive physician time

6. Safety

• The test must be safe to administer with minimal risk

7. Rapidity

• Results must be available quickly so that prompt follow-up can be arranged

8. Cost-effectiveness

• The test should be relatively inexpensive so it can be applied to large populations

"Tests most likely to fulfil one condition may be least likely to fulfil another - the choice must often be based on compromise." - Park's PSM

Answer 2: NP-NCD + CBAC Form (5+5 marks)

Part A: Objectives of NP-NCD / NPCDCS (5 marks)

Objectives of NPCDCS (Major Objectives):

1. Prevent and control common NCDs through behaviour and lifestyle changes - promoting healthy diet, physical activity, tobacco and alcohol cessation, stress management
2. Provide early diagnosis and management of common NCDs - opportunistic screening of persons above 30 years of age for diabetes (blood glucose), hypertension (BP measurement), and cancers
3. Build capacity at various levels of health care (sub-centre, PHC, CHC, District Hospital) for prevention, diagnosis, and treatment of NCDs
4. Train human resources within the public health setup - doctors, paramedics, and nursing staff to cope with the increasing NCD burden
5. Establish and develop capacity for palliative and rehabilitative care for chronic, debilitating, and progressive NCD patients

Strategies:

• Health promotion through mass media, IEC/BCC
• Opportunistic screening at sub-centres (BP by ANM, blood sugar by strip method)
• NCD Clinics at CHC and District Hospital level
• NCD Cells at national, state, and district levels for implementation and monitoring
• Integration with RNTCP (TB-Diabetes co-morbidity), AYUSH, RBSK

Activities at different levels:

Part B: CBAC (Community Based Assessment Checklist) Form for Early Detection of NCDs (5 marks)

• To identify individuals at risk or with early symptoms of NCDs in the community
• To stratify risk and prioritize referral to health facilities
• Helps shift NCD detection from health facilities to the community level

Components/Parameters of CBAC Form:

• Name, age, sex, address, contact number

1. Tobacco use (smoking/smokeless)
2. Alcohol consumption
3. Physical inactivity (sedentary lifestyle)
4. Unhealthy diet (less fruit and vegetable intake)

CBAC Risk Scoring:

• Each item is scored and a total risk score is calculated
• Based on the score, individuals are categorized as low, medium, or high risk
• High-risk individuals are referred to sub-centre/PHC/CHC for confirmatory testing and management

Who administers it?

• ASHA at household level (annual visits to all persons >30 years)
• Results entered in health records and linked to the NCD registry

Significance:

• Enables population-level surveillance for NCDs at community level
• Facilitates demand generation for NCD services
• Helps achieve the NP-NCD target of universal screening of all persons >30 years
• Bridges the gap between community and health facility through systematic follow-up by ASHA/ANM

Q.6 Short Notes (Any 2 out of 3) — 2×6=12 marks

Short Note 1: Confidence Interval - Concept and Interpretation

Concept

A confidence interval is a range of values, calculated from sample data, that is likely to contain the true value of an unknown population parameter.

CI = x̄ ± Z × (SD/√n)

• x̄ = sample mean
• Z = Z-score corresponding to the confidence level (Z = 1.96 for 95% CI; Z = 2.58 for 99% CI)
• SD = standard deviation
• n = sample size

• 95% CI = 130 ± 1.96 × (20/√100) = 130 ± 3.92 = [126.08, 133.92]

Confidence Levels

As the confidence coefficient increases, the width of the interval increases (wider = more certain, but less precise).

Interpretation

"If the same study were repeated 100 times and a 95% CI was calculated each time, approximately 95 of those intervals would contain the true population parameter."

Applications in Public Health / PSM

1. Interpretation of study results - A CI that does not cross the null value (1.0 for RR/OR; 0 for difference) indicates statistical significance
2. Assessing precision - Narrow CI = more precise estimate; wide CI = less precise (often due to small sample size)
3. Clinical significance vs statistical significance - CI conveys both statistical significance AND clinical importance
4. Meta-analysis / Systematic reviews - Forest plots display CI for each study and the pooled estimate

• If the 95% CI for an Odds Ratio (OR) does NOT include 1.0 → statistically significant (p < 0.05)
• If the 95% CI INCLUDES 1.0 → not statistically significant (p > 0.05)

Short Note 2: Visual Impairment and Blindness - NPCB&VI

Definitions (as per NPCB&VI / WHO)

A person who is unable to count fingers from a distance of 3 metres (visual acuity < 3/60 or < 10/200 in the better eye with best correction, or visual field < 10°) is considered blind.

• National Blindness Survey 2006-07: 1.0%
• National Survey on Blindness 2015-19: 0.36% (projected)
• Goal of NPCB&VI: Reduce to 0.3% by 2020

Major Causes of Blindness in India (National Survey 2015-19)

Prevention and Control under National Programme (NPCB&VI)

• Renamed from "National Programme for Control of Blindness (NPCB)" to "National Programme for Control of Blindness and Visual Impairment (NPCB&VI)"
• Centrally sponsored scheme (60:40 centre-state; 90:10 for NE states)
• Operates under "Vision 2020: The Right to Sight" (WHO global initiative, launched 1999)

1. Cataract (66.2% of blindness):
   • Free cataract surgery through government hospitals, eye camps, NGOs
   • Intraocular Lens (IOL) implantation
   • Mobile ophthalmic units for remote areas
   • Target: Increase cataract surgical rate (CSR) to 6000+ per million/year
2. Refractive Errors:
   • School eye screening programmes
   • Free spectacles to school children (Classes 6-12)
   • Low Vision Clinics
3. Corneal Blindness:
   • Eye donation promotion and corneal transplantation
   • National Eye Bank network
   • Control of trachoma (antibiotic treatment - SAFE strategy)
4. Childhood Blindness:
   • Vitamin A supplementation (every 6 months, age 9 months to 5 years) under Universal Immunization Programme
   • ROP screening in NICUs
   • School eye screening
5. Glaucoma / Diabetic Retinopathy:
   • Establishment of Vitreo-Retinal Surgery Centres
   • Laser treatment facilities at district level
6. Infrastructure Development:
   • Dedicated eye units at district hospitals
   • Contractual ophthalmic surgeons, ophthalmic assistants, eye donation counsellors
   • District Mobile Ophthalmic Units for difficult areas
   • Sub-district level primary eye care through MPWs/ANMs
7. Primary Eye Care at Community Level:
   • Training of village health workers, MPWs for basic eye care
   • Common eye conditions (conjunctivitis, foreign body, trachoma, xerophthalmia) managed at periphery

Short Note 3: Telemedicine in Public Health

Definition

"The delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for diagnosis, treatment, prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers."

Concept and Evolution

• Began with simple telephone consultations
• Now includes video consultations, remote monitoring, AI-assisted diagnostics, mobile health (mHealth), and e-health platforms
• India's Telemedicine Practice Guidelines were released by MoHFW in March 2020 (updated 2020, Gazette notification)

Types of Telemedicine

Applications in Public Health (India)

1. eSanjeevani - India's national teleconsultation platform (MoHFW)
   • Two models: Doctor-to-Doctor (Hub & Spoke) and Patient-to-Doctor (OPD)
   • Implemented at Health & Wellness Centres (HWCs) under Ayushman Bharat
2. Disease Surveillance - IDSP (Integrated Disease Surveillance Programme) uses ICT for weekly disease reporting (S/P/L forms)
3. Tele-ophthalmology - Remote screening for diabetic retinopathy, ROP (linked to NPCB&VI)
4. Tele-psychiatry - Mental health consultations in remote areas (National Tele Mental Health Programme - iCall, Vandrevala Foundation helpline)
5. Tele-dermatology - Screening for skin conditions including leprosy in remote areas
6. Tele-ICU / Tele-ECG - Remote cardiac monitoring and ICU support
7. Medical Education - CME, training of ASHAs, ANMs using digital platforms

Advantages of Telemedicine in Public Health

1. Overcomes geographic barriers - reaches remote/rural/tribal areas
2. Reduces patient travel time, cost, and burden
3. Decongests tertiary hospitals - reduces unnecessary referrals
4. Improves specialist access in underserved areas
5. Enables continuous chronic disease monitoring (DM, HTN)
6. Cost-effective health service delivery
7. Facilitates multidisciplinary consultations without physical co-location
8. Pandemic utility - COVID-19 demonstrated value (contact-free care)

Limitations / Challenges

1. Digital divide - lack of internet connectivity in rural areas
2. Absence of physical examination - clinical limitations
3. Data privacy and security concerns
4. Need for legal and ethical framework (India: Telemedicine Practice Guidelines 2020)
5. Technology literacy among patients and providers
6. Reliability of remote diagnostic devices

Ethical/Legal Aspects (India - 2020 Guidelines)

• Registered Medical Practitioners (RMPs) can prescribe medications via teleconsultation
• Certain drugs (narcotics, psychotropics) CANNOT be prescribed via telemedicine
• Patient consent is mandatory
• AYUSH practitioners can practice within their scope via telemedicine

Q.7 Short Notes (Any 3 out of 4) — 3×6=18 marks

Short Note 1: Legislation for Prevention of Tobacco-Related Disease

Background

Key Legislation

A. COTPA, 2003 (Cigarettes and Other Tobacco Products Act)

• Passed by Parliament in April 2003; notified in Gazette on 25th February 2004

B. WHO - Framework Convention on Tobacco Control (FCTC)

• First international public health treaty under WHO
• India ratified in 2004
• Mandates comprehensive tobacco control policies: taxation, smoke-free environments, advertising bans, cessation support, illicit trade control, packaging/labelling

C. National Tobacco Control Programme (NTCP)

• Launched under 11th Five Year Plan (2007-08); pilot in 16 districts, 9 states
• Now covers 108 districts in 31 states
• Main components:
  1. Public awareness and mass media campaigns
  2. Tobacco product testing laboratories (regulatory capacity under COTPA)
  3. Mainstreaming within NRHM framework
  4. Research on alternate crops and livelihood
  5. Monitoring, evaluation and surveillance (Adult Tobacco Survey - GATS)
  6. Dedicated tobacco control cells at state/district level
  7. Training of health workers, NGOs, school teachers
  8. School programmes
  9. Tobacco cessation facilities (helpline: iQuit - 1800-11-2356)

D. Other Measures

• Gutka ban - 34 states/UTs banned gutka and pan masala containing tobacco/nicotine (2014-15) under Food Safety Regulations
• Prohibition of sale of loose cigarettes (via COTPA amendment)
• MPOWER strategy (WHO): Monitor, Protect, Offer cessation, Warn, Enforce ban on ads, Raise taxes

Short Note 2: International Health Regulations (IHR) and Traveller's Health / Preparedness and Response to Biological Emergencies (Bioterrorism)

A. International Health Regulations (IHR 2005)

• 4 diseases ALWAYS notifiable: Smallpox, Poliomyelitis (wild-type), Human influenza (new subtype), SARS
• Events assessed using decision algorithm: Cholera, Pneumonic plague, Yellow fever, Viral haemorrhagic fevers, West Nile fever, others

1. National legislation, policy and financing
2. Coordination and IHR focal point communications
3. Surveillance
4. Response
5. Preparedness
6. Risk communication
7. Human resources
8. Laboratory

• IHR governs requirements for Points of Entry (airports, seaports, ground crossings)
• Health documents required: Yellow fever vaccination certificate (for endemic countries)
• Measures: Inspection of ships, aircraft; quarantine of ill travellers

B. Preparedness and Response to Biological Emergencies (Bioterrorism)

1. Surveillance and Early Detection:
   • Syndromic surveillance for unusual cluster of diseases
   • Laboratory diagnostic capacity (BSL-3/4 labs)
   • Reporting to WHO under IHR
2. Communication:
   • Rapid communication between health authorities
   • Risk communication to the public (to prevent panic)
   • International alerts through WHO - Health Alert Network (HAN)
3. Response:
   • Stockpiling of vaccines, antitoxins, antibiotics
   • Personal Protective Equipment (PPE) for response teams
   • Mass casualty management protocols
   • Decontamination procedures
4. India's Framework:
   • National Disaster Management Authority (NDMA) - biological disaster guidelines
   • IDSP (Integrated Disease Surveillance Programme) for unusual event detection
   • National Centre for Disease Control (NCDC) - nodal agency
   • Emergency Operations Centre (EOC)
   • Designated quarantine hospitals

Short Note 3: Operational Research in Community Medicine with Suitable Examples

Definition

"The search for knowledge on strategies, interventions, or tools that can enhance the quality, effectiveness, or coverage of programmes in which the research is being conducted." (WHO/TDR)

Key Characteristics

1. Conducted within an existing programme (not outside)
2. Aims to solve an operational problem facing the programme
3. Results are used to inform programme decisions - directly actionable
4. Uses both quantitative and qualitative methods
5. Conducted by programme staff themselves (not just academic researchers)

Types of Operational Research

Steps in Operational Research

1. Identify the operational problem
2. Review existing information/literature
3. Formulate research questions/objectives
4. Design the study (protocol)
5. Collect data
6. Analyse and interpret results
7. Disseminate findings to programme managers
8. Implement changes based on findings

Suitable Examples

1. RNTCP / TB Programme:
   • OR question: "Why is treatment defaulter rate high in urban slums?"
   • Finding: Patients lose contact due to work migration
   • Action: Community DOTS by ASHA, video-observed therapy (VOT)
2. Malaria Control:
   • OR question: "Why is ITN (insecticide-treated bed net) use low despite distribution?"
   • Finding: Cultural practices, lack of awareness
   • Action: Targeted IEC campaigns
3. Immunization Programme:
   • OR question: "What are reasons for vaccine drop-out in children?"
   • Finding: Distance from sub-centre, AEFI fears
   • Action: Village Health and Nutrition Days (VHNDs)
4. PPTCT Programme:
   • OR question: "What proportion of HIV+ pregnant women receive complete ARV prophylaxis?"

Difference from Conventional Research

Q.8 Very Short Answer (Any 5 out of 6) — 5×2=10 marks

1. Describe Cluster Sampling Method with Suitable Example

1. Divide population into clusters (e.g., villages, schools, wards)
2. Randomly select required number of clusters
3. Study all individuals in selected clusters

• Single-stage: All members of selected clusters are studied
• Two-stage: A random sample of members is studied within selected clusters

• 30 clusters randomly selected (using PPS - Probability Proportional to Size)
• 7 children selected per cluster
• Total sample = 210 children
• Used to estimate vaccination coverage in a district/state

• Cost-effective and administratively convenient
• Useful when complete population list is unavailable
• Practical for large geographically dispersed populations

• Less precise than simple random sampling (design effect/DEFF)
• Intra-cluster homogeneity may bias results

2. Enumerate Screening Tests for Colorectal or Cervical Cancer

A. Screening Tests for Cervical Cancer

B. Screening Tests for Colorectal Cancer

3. Define Type II Error

Type II error (β error) is the failure to reject a null hypothesis when it is actually false - i.e., concluding there is NO statistically significant difference/association when in reality one DOES exist.

β = P (accepting H₀ when H₁ is true)

Power = 1 - β Power is the probability of correctly detecting a true difference. Desirable power = 80% or more (β ≤ 0.20)

• Increase sample size
• Increase significance level (α) - though this increases Type I error
• Use more sensitive measuring instruments

4. Enumerate Any Four Vaccines Covered under the Open Vial Policy

1. Not expired
2. Stored under appropriate cold-chain conditions (2-8°C)
3. VVM (Vaccine Vial Monitor) has not reached discard point
4. No visible contamination/turbidity
5. Sterile technique was used when withdrawing doses

1. OPV (Oral Polio Vaccine) - opened vial usable for 28 days if OVP criteria met
2. DPT (Diphtheria, Pertussis, Tetanus) - opened vial usable for up to 28 days
3. TT (Tetanus Toxoid) - opened vial usable for 28 days
4. Hepatitis B vaccine - opened vial usable for 28 days
5. DT (Diphtheria-Tetanus) vaccine

• BCG - must be discarded within 4-6 hours of reconstitution
• Measles/MR vaccine - must be discarded within 4-6 hours of reconstitution
• JE vaccine - discarded after session
• Any reconstituted (lyophilized) vaccine

5. Enumerate the Primary Prevention (Modes of Intervention) for Oral Cancer

Risk Factors for Oral Cancer:

• Tobacco (smoking + smokeless - gutka, khaini, zarda, paan with tobacco)
• Alcohol consumption (especially combined with tobacco - synergistic effect)
• HPV infection (especially type 16)
• Betel nut/areca nut (with or without tobacco)
• Poor oral hygiene, ill-fitting dentures
• Sun exposure (lip cancer)
• Nutritional deficiencies (Vit A, C, E)
• OSMF (Oral submucous fibrosis) - pre-malignant condition

Modes of Primary Prevention for Oral Cancer:

1. Tobacco cessation:
   • Cessation counselling at all health facilities
   • National Tobacco Quitline (1800-11-2356)
   • Nicotine Replacement Therapy (NRT)
   • Brief advice by healthcare providers (5 A's: Ask, Advise, Assess, Assist, Arrange)
2. Alcohol reduction/cessation:
   • Counselling, de-addiction services
   • Community awareness programmes
3. Avoidance of betel nut/areca nut and its products
4. Health education and IEC/BCC:
   • School-based education on tobacco and alcohol harms
   • Mass media campaigns (anti-tobacco days - World No Tobacco Day, May 31)
   • Poster, leaflets, street plays
5. Legislation/Policy measures:
   • COTPA 2003 - banning sale to minors, near schools; pictorial warnings
   • Gutka ban under Food Safety Act
   • Tobacco-free educational institution policy
6. Nutritional interventions:
   • Promote diet rich in fruits and vegetables (antioxidants - Vit A, C, E, beta-carotene)
   • Vitamin A supplementation programmes
7. HPV Vaccination:
   • HPV vaccine (Gardasil/Cervarix) protects against HPV 16/18 - relevant for oropharyngeal cancer
8. Oral hygiene promotion:
   • Regular dental check-ups
   • Proper fitting of dentures

6. Enumerate Four Ethical Principles of Biomedical Research

1. Autonomy (Respect for Persons)

• Respect for the individual's right to make their own decisions
• Requires: Informed Consent (voluntarily given, with full disclosure of risks/benefits/alternatives)
• Special protection for vulnerable populations (children, prisoners, mentally ill, pregnant women)
• Components of informed consent: Disclosure, Comprehension, Voluntariness, Competence, Consent

2. Beneficence (Do Good)

• Obligation to maximize potential benefits to research participants and society
• Research must have scientific merit and potential for positive outcomes
• Risk-benefit analysis must favour benefit
• "Do good" - actively promote the well-being of participants

3. Non-maleficence (Do No Harm)

• Obligation to avoid causing harm to participants
• "Primum non nocere" - first, do no harm
• Minimize physical, psychological, social, and economic risks
• Risks must be reasonable and minimized as far as possible

4. Justice (Fairness)

• Fair distribution of the benefits and burdens of research
• Participants who bear the risks should also share in the benefits
• No exploitation of vulnerable/disadvantaged groups
• Equal access to research benefits (e.g., vaccines developed through research must be accessible to communities that participated)

Additional Principles (often added):

• Veracity (truthfulness/honesty)
• Fidelity (keeping promises, loyalty)
• Confidentiality (protection of participant data)

Key Documents:

• Nuremberg Code (1947) - voluntary consent is absolutely essential
• Declaration of Helsinki (1964, revised 2013) - WMA guidelines for medical research
• Belmont Report (1979) - Respect for persons, Beneficence, Justice
• ICMR National Ethical Guidelines (India, 2017) - 12 principles of ethical research in India

Health Advice to Travellers

(As per K. Park's Textbook of Preventive and Social Medicine)

Emporiatrics

Why Travellers Face Special Health Risks

• Crowding and long hours of waiting
• Disruption of eating habits
• Changes in climate and time zones
• These factors may provoke nausea, indigestion, extreme fatigue and insomnia

• Malaria, dengue, filariasis
• Giardiasis, intestinal parasites
• Typhoid and paratyphoid fever
• Viral hepatitis (A, B, E)
• STD and HIV/AIDS
• Influenza

Many of these may NOT manifest immediately but occur during a varying period after the traveller returns home. Poor hygiene by food handlers, poor water quality, and improper waste disposal are important causes.

Travellers have a personal responsibility to recognize these risks, which can be minimized by immunization and chemoprophylaxis or chemotherapy.

Specific Health Advice (Numbered Recommendations - Park's)

(1) Environmental Hazards

• Avoid bathing with polluted water - may cause ear, eye, and skin infections
• Excessive heat and humidity or over-exertion may lead to exhaustion from loss of water and salt
• Take measures to prevent insect bites

(2) Insect Bite Prevention

• Use insect repellents (DEET-based)
• Sleep under insecticide-treated bed nets
• Wear long-sleeved clothing and long trousers, especially at dusk and dawn
• Use permethrin-treated clothing in highly endemic areas

(3) Diarrhoeal Diseases

• "Be careful what you eat" is common advice - diarrhoea affects an estimated 20-50% of all travellers
• Contaminated food and drinks are the most common source
• Unsafe items to avoid:
  • Unpasteurized milk
  • Non-bottled drinks
  • Uncooked food (except fruits/vegetables that can be peeled or shelled)
• Safe practices:
  • Food should be thoroughly and freshly cooked
  • Use boiled water or bottled mineral water
  • Appearance of food is NO guide to its safety
• Travellers should be aware of oral rehydration fluids (ORS containing salt and glucose) for countering dehydration

(4) Malaria

• There is a high risk of acquiring malaria in endemic areas
• Travellers are advised to protect themselves by chemoprophylaxis
• Drug prophylaxis should begin at the latest on the day of arrival in malarious areas
• Continue chemoprophylaxis for 4-6 weeks after leaving the malarious area

(5) Hepatitis A

• Normal human immunoglobulin in a dose of 0.02-0.05 mg/kg of body weight is recommended every 4 months
• Immunoglobulin should NOT be given within 3 weeks before, or until 2 weeks after, administration of a live vaccine
• A highly safe inactivated HAV vaccine is available

(6) Hepatitis E

• No vaccine available against hepatitis E
• Immunoglobulin prepared in Europe/USA does not give much protection
• Only effective measure: Avoidance of contaminated food and water

(7) Hepatitis B

• Hepatitis B vaccines are safe and available
• Complete course = 3 doses:
  • First two doses: 1 month apart
  • Third dose: approximately 6 months later

(8) STD and HIV

• Avoidance of sex altogether, OR limit to a single faithful, uninfected partner
• Use of condom is an important preventive measure
• To reduce risk of HIV and hepatitis B from syringes/needles:
  • Avoid injectable drugs
  • If injection is essential, ensure needle and syringe come from a sterile pack

(9) Yellow Fever

• Vaccination certificate for yellow fever is the ONLY certificate required for international travel (under IHR)
• Yellow fever vaccine is recommended for travellers to yellow fever endemic zones
• Validity of certificate: Begins 10 days after vaccination
• Since 11th July 2016 (IHR 2005 amendment): Certificate is valid for the lifetime of the person vaccinated (no longer 10 years - booster NOT required)
• Certificate must be issued at an officially designated centre and stamped by the Ministry of Health
• India requires vaccination of infants ≥9 months of age too

• Africa: Angola, Benin, Burkina Faso, Cameroon, Congo, Ethiopia, Ghana, Kenya, Nigeria, Uganda and others
• Americas: Brazil, Bolivia, Colombia, Ecuador, French Guiana, Peru, Venezuela and others

(10) Tetanus

• It is a wise precaution to have a booster dose of tetanus toxoid if 10 years or more have elapsed since the last injection of a complete course or booster

Medical Kit for Travellers

WHO Reference

For the benefit of travellers, WHO publishes annually a booklet - "International Travel and Health, Vaccination requirements and Health advice" - which provides guidance on main health risks in different parts of the world and precautions against them.

Summary Table - Vaccinations for Travellers

SECTION - I

Q.1 Structured Long Questions (Any 1 out of 2)

Answer 1: Maternal Mortality Ratio (MMR) (2+1+1+3+3 marks)

Part A: Definition of MMR (2 marks)

MMR = (Number of maternal deaths / Number of live births) × 1,00,000

Part B: Current Status of MMR in India (1 mark)

• MMR in India (SRS 2018-20): 97 per 1,00,000 live births
• India has achieved the MDG target (<109) but has not yet met the SDG target of <70 by 2030
• State variation: Kerala has lowest MMR (~19); Assam has highest (~195)
• Major causes: Haemorrhage (most common ~38%), Sepsis, Hypertensive disorders, Anaemia, Obstructed labour

Part C: Enumerate Health Programmes/Schemes to Decrease MMR in India (1 mark)

1. Janani Suraksha Yojana (JSY)
2. Janani Shishu Suraksha Karyakaram (JSSK)
3. Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA)
4. LaQshya Programme
5. Surakshit Matritva Aashwasan (SUMAN)
6. Navjaat Shishu Suraksha Karyakram (NSSK)
7. Dakshata Programme
8. PPIUCD and postpartum services
9. Skilled Birth Attendant (SBA) training
10. Anaemia Mukt Bharat (AMB)

Part D: Explain Any Two Health Programmes in Detail (3+3 marks)

• Launched in 2005 under NRHM
• A safe motherhood intervention to reduce maternal and neo-natal mortality by promoting institutional delivery among poor pregnant women
• Conditional Cash Transfer scheme - cash incentive to mother + ASHA for institutional delivery

• Below Poverty Line (BPL) pregnant women
• In Low Performing States (LPS) - all pregnant women (SC/ST regardless of age or parity; others: ≥2 live births)
• In High Performing States (HPS) - BPL women age ≥19 years, up to 2 live births

• ASHA acts as a link between the woman and government for antenatal care, delivery, and postnatal care
• Target: Promote ≥3 ANC visits, institutional delivery, postnatal care at 7 and 42 days
• Has significantly increased institutional delivery rate in India (from ~38% in 2005 to >90% currently)

• Launched on 9th June 2016
• Provides free, assured, comprehensive, quality antenatal care to all pregnant women on the 9th of every month at government health facilities

• Minimum package of ANC services: Weight, BP, abdominal examination, Haemoglobin, urine analysis, blood group
• High-risk identification and management
• Services provided by OBGY specialists, physicians, private practitioners (voluntarily)

• Special focus on identification and follow-up of high-risk pregnancies (anaemia, hypertension, gestational diabetes, previous caesarean)
• Pink colour-coded stickers on ANC cards for high-risk pregnancies (for tracking)
• Drives institutional delivery
• Implemented in all states/UTs

Answer 2: Mental Health (1+3+6 marks)

Part A: Definition of Mental Health (1 mark)

"A state of well-being in which every individual realizes his or her own potential, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to his or her community."

Part B: Etiology of Mental Illness (3 marks)

• Genetic: Family history (e.g., schizophrenia, bipolar disorder have strong genetic component)
• Biochemical: Neurotransmitter imbalances (dopamine excess in schizophrenia, serotonin deficiency in depression)
• Neurological: Brain trauma, infections (neurocysticercosis, encephalitis), epilepsy
• Endocrine: Thyroid disorders, Cushing's disease, postpartum hormonal changes
• Perinatal: Birth complications, prematurity, intrauterine infections

• Adverse childhood experiences (abuse, neglect)
• Personality traits (perfectionism, neuroticism)
• Cognitive distortions and learned helplessness
• Grief, loss, bereavement
• Childhood trauma and PTSD

• Poverty, unemployment, homelessness
• Social isolation and lack of social support
• Migration and acculturation stress
• Urbanization and overcrowding
• Domestic violence, marital discord
• Substance abuse (alcohol, cannabis, opioids)
• Life events: Divorce, job loss, death of loved one

• Stigma, discrimination
• Cultural beliefs about mental illness (demonization, supernatural causation)

Part C: Objectives, Strategies, and Components of the National Mental Health Programme (NMHP) of India (6 marks)

Objectives:

1. To ensure availability and accessibility of minimum mental health care for all in the foreseeable future, particularly the most vulnerable and underprivileged sections of population
2. To encourage application of mental health knowledge in general health care and in social development
3. To promote community participation in mental health services development and stimulate self-help in the community

Strategies:

1. Integration of mental health with primary health care through NMHP
2. Provision of tertiary care institutions for treatment of mental disorders
3. Eradicating stigmatization of mentally ill patients and protecting their rights through regulatory institutions (Central/State Mental Health Authorities)

Components:

• Implementation at district level
• Training of doctors, paramedics, and nurses at district level for basic psychiatric care
• Outpatient services at district hospital
• Inpatient services (10 beds at district hospital)
• Community outreach camps
• IEC activities
• Currently covers 517 districts in 36 states

• Centres of Excellence in mental health (NIMHANS, LGBRIMH, RINPAS, etc.)
• Training centres for under/postgraduate training in psychiatry
• 11 institutions identified for training primary care physicians and paramedics

• Epidemiological studies on mental health burden
• Operational research

• Replaced Mental Health Act 1987
• Right to access mental health care
• Prohibition of cruel treatment (electroconvulsive therapy without anaesthesia prohibited)
• Advance directive for treatment
• Decriminalization of suicide attempt (Section 309 IPC - no longer criminal)

• National Tele Mental Health Programme
• NIMHANS-coordinated helplines

Q.2 Case Based Scenario/Applied Short Notes (Any 2 out of 3)

Answer 1: Couple with Child Having Genetic Disorder - Genetic Counselling

Pre-conception Counselling:

1. Establish exact diagnosis of the genetic disorder in the first child (karyotyping, molecular diagnosis, metabolic studies)
2. Assess recurrence risk:
   • Autosomal dominant: 50% risk each pregnancy
   • Autosomal recessive: 25% risk
   • X-linked: depends on the condition
   • Chromosomal (e.g., Down syndrome): Depends on type (translocation vs. trisomy)
3. Carrier testing of parents:
   • Both parents should undergo genetic testing
   • Example: For sickle cell/thalassaemia - Hb electrophoresis
   • For chromosomal translocations - karyotyping
4. Family pedigree analysis - identify other affected members
5. Consanguinity counselling - advise against consanguineous marriages (doubles recurrence risk for autosomal recessive conditions)

Antenatal Diagnosis (if couple decides to conceive):

1. Prenatal diagnosis:
   • Chorionic Villus Sampling (CVS) at 10-12 weeks - for chromosomal/molecular diagnosis
   • Amniocentesis at 15-18 weeks - chromosomal analysis (karyotype), biochemical
   • Fetal blood sampling (cordocentesis) - for haematological disorders
   • Maternal serum screening (Triple/Quadruple test) - for Down syndrome (AFP, hCG, estriol, inhibin A)
   • Fetal ultrasonography - structural defects (NT scan at 11-14 weeks; anomaly scan at 18-20 weeks)
   • Preimplantation Genetic Diagnosis (PGD) via IVF - select unaffected embryos before implantation
2. MTP (Medical Termination of Pregnancy): If prenatal diagnosis confirms affected fetus, MTP can be offered under MTP Act 2021 (up to 24 weeks with specialist opinion)
3. Adoption as an alternative to biological conception in high recurrence risk situations
4. Long-term support and follow-up - psychosocial counselling for parental anxiety and grief

Answer 2: Newborn with Cleft Lip - Management as PHC Medical Officer

Explanation to Parents:

1. What is cleft lip?
   • A congenital defect (present at birth) due to failure of fusion of facial processes during 4th-8th week of intrauterine life
   • May be unilateral or bilateral, complete or incomplete
   • May be associated with cleft palate (examine palate carefully)
   • Does NOT affect intelligence; child will lead a normal life after surgical correction
2. Immediate Management at PHC:
   • Feeding counselling: Breastfeeding may be difficult; teach special feeding techniques (upright position, special cleft nipple/bottle, breast shield)
   • Monitor for adequate weight gain and growth
   • Ensure no aspiration during feeding
   • Refer to district hospital/tertiary centre for specialist care
3. Definitive Treatment (Surgical):
   • Cleft lip repair (Cheiloplasty): Done at 3 months of age (Rule of 10s: 10 weeks, 10 lbs weight, Hb 10 g/dL)
   • Cleft palate repair (Palatoplasty): Done at 9-18 months before speech development
   • Rhinoplasty for nasal deformity - may be needed later
4. Multidisciplinary team approach:
   • Plastic surgeon, dental surgeon, ENT specialist, speech therapist, orthodontist, psychologist
5. Government Schemes:
   • Rashtriya Bal Swasthya Karyakram (RBSK): Free screening and treatment of birth defects including cleft lip/palate under NRHM. DEIC (District Early Intervention Centre) provides free corrective surgery.
   • National Rural Health Mission - referral and free treatment
6. Reassurance: Surgery gives excellent cosmetic and functional results. The child can speak, eat, and live normally.
7. Genetic counselling for family planning - recurrence risk ~4% for next child (multifactorial inheritance)

Answer 3: 10-Day-Old Infant with Yellow Discoloration Extending to Palm and Sole

1. Most Likely Diagnosis (1 mark)

• Hepatitis B vaccine-related jaundice (mentioned by student as "vaccine-induced jaundice")
• However, more likely: Hemolytic jaundice or Sepsis-related jaundice given:
  • Jaundice extending to palms and soles (indicating bilirubin >15-20 mg/dL)
  • Age 10 days (physiological jaundice resolves by day 14, but this severity suggests pathological)
  • Poor feeding, lethargy, arousable
  • Weight 2.8 kg (low weight)

2. Management Plan (4 marks)

• Measure Serum Total Bilirubin (STB) - urgently
• Check for Direct (Conjugated) vs Indirect bilirubin ratio
• Blood investigations: CBC, blood group (mother and baby), DCT (Coombs test), Reticulocyte count, LFT, blood culture (if sepsis suspected)
• Assess for signs of acute bilirubin encephalopathy: arching, high-pitched cry, seizures

• Conventional phototherapy if STB is above threshold for age (using Bhutani nomogram)
• Jaundice extending to palms and soles (zone V) = bilirubin >15-20 mg/dL = intensive phototherapy required
• Intensive phototherapy: Special blue light (460-490 nm) - light output >30 µW/cm²/nm; expose maximum skin surface
• Maintain hydration - increase feeds by 10-20%; supplement with IV fluids if poor oral intake
• Monitor STB every 4-6 hours during intensive phototherapy

• If bilirubin approaches exchange transfusion threshold on nomogram
• If signs of acute bilirubin encephalopathy
• Double volume exchange transfusion (160-180 mL/kg)

• Sepsis: Blood culture + IV antibiotics (Ampicillin + Gentamicin)
• Haemolytic disease: IVIG if due to ABO/Rh incompatibility

• Continue breastfeeding (do NOT stop breastfeeding unless specifically indicated)
• Ensure adequate caloric intake

3. Advice to Mother Regarding Vaccination (1 mark)

• The child has received OPV zero dose and Hep B (Birth dose) - this is correct and appropriate
• Reassure mother that the jaundice is NOT caused by the Hepatitis B vaccine
• Continue the UIP vaccination schedule:
  • At 6 weeks: OPV-1, IPV-1, DPT-1 (Pentavalent-1 = DPT+HepB+Hib), Rotavirus-1, PCV-1
  • At 10 weeks: OPV-2, Pentavalent-2, Rotavirus-2, PCV-2
  • At 14 weeks: OPV-3, IPV-2, Pentavalent-3, Rotavirus-3, PCV-3
  • At 9 months: Measles-Rubella (MR-1), JE (in endemic areas)
• No vaccination until jaundice resolves - defer current scheduled vaccines until baby is clinically well
• Emphasize importance of completing all vaccines for child's protection

Q.3 Short Notes (Any 3 out of 4) — 3×6=18 marks

1. Ethical and Legal Implications of Breach of Fiduciary Duty in Medical Practice

• Trust (patient trusts doctor with sensitive information and bodily autonomy)
• Confidence (patient relies on doctor's expertise)
• Vulnerability (patient is in a weaker position)

1. Duty of loyalty - act in patient's best interest, not doctor's financial/personal interests
2. Duty of disclosure - full, honest communication; informed consent
3. Duty of confidentiality - patient information cannot be disclosed without consent (with legal exceptions)
4. Duty of care - reasonable standard of medical care
5. Duty of non-abandonment - cannot abandon patient without adequate notice

• Performing unnecessary procedures for financial gain
• Disclosing patient information without consent (breach of confidentiality)
• Sexual misconduct with patients
• Failure to obtain informed consent
• Not disclosing conflict of interest
• Prescribing drugs to maintain dependency for financial benefit

• Violates principles of autonomy, beneficence, non-maleficence, and justice
• Moral injury to the physician
• Erosion of trust in the medical profession
• Harm to patient (physical, psychological, financial)
• Violates the Hippocratic principle - "First, do no harm"
• Breach of Declaration of Geneva ("The health of my patient will be my first consideration")

1. Civil Liability (Medical Negligence):
   • Patient can sue for damages in Consumer Protection Act 2019 (COPRA)
   • District/State/National Consumer Dispute Redressal Commission
   • Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations 2002
   • Compensation for physical harm, mental agony, financial loss
2. Criminal Liability:
   • Gross negligence → IPC Section 304A (causing death by negligence) → up to 2 years imprisonment
   • Sexual misconduct → IPC Section 376 (rape), POCSO Act
3. Professional Consequences:
   • Complaint to Medical Council of India (MCI) / National Medical Commission (NMC)
   • Suspension or permanent removal from medical register (erasure)
   • Loss of license to practice
4. IPC and Other Acts:
   • Breach of confidentiality (causing harm) may lead to action under relevant IPC sections
   • RTI (Right to Information) and Medical Records Regulations

2. Demographic Transition and Its Context in India

Demographic Transition is the theory that explains the historical process of change in a country's population from high birth rates and high death rates to low birth rates and low death rates, passing through intermediate stages of population growth.

Stages of Demographic Transition:

Mechanism:

• Death rate falls first due to improved sanitation, nutrition, medical care, and public health
• Birth rate takes longer to fall - social, cultural, and economic factors
• The gap between falling death rate and still-high birth rate creates population explosion (Stage 2-3)
• Eventually birth rate also falls with urbanization, education, women's empowerment, and family planning

India's Context:

1. Mortality decline was rapid post-independence (due to antibiotics, DDT, green revolution)
2. Fertility decline has been slower - due to illiteracy, poverty, son preference, child marriage
3. Regional variation is marked:
   • Kerala, TN, AP, Karnataka: Stage 4 (TFR <2.1, NRR <1)
   • UP, Bihar, MP, Rajasthan: Stage 2-3 (TFR still >3.0)
4. Demographic dividend potential - large working-age population (15-64 years) through 2040s
5. Ageing population emerging - elderly (>60 years) growing rapidly

• Short term: Population growth continues due to momentum
• Long term: Population stabilization expected by 2064 (UN estimate)
• India overtook China as world's most populous nation in 2023

3. Adolescent Reproductive and Sexual Health (ARSH) Programme

Goal:

Programmatic Approaches:

1. Adolescent Friendly Health Clinics (AFHC)

• Fixed-day clinics at PHC, CHC, District Hospital levels
• Currently 6,302 AFHCs functional across India
• Services to >2.5 million adolescents
• Services include: Contraceptive provision, management of menstrual problems, RTI/STI management, antenatal care for married adolescents, anaemia management
• Environment: Non-judgmental, confidential, peer-friendly

2. Facility-Based Counselling Services

• Dedicated ARSH counsellors (currently 881 counsellors across India)
• Topics: Nutrition, puberty, RTI/STI prevention, contraception, delaying marriage and childbearing, sexual abuse, substance misuse, mental health
• 1439 ICTC counsellors in 23 states also provide sexual/reproductive health counselling to adolescents

3. Community-Based Outreach Activities

• Conducted in schools, colleges, teen clubs, vocational training centres
• During Village Health Nutrition Days (VHND), health melas
• Collaboration with self-help groups
• Peer educators and ASHA workers trained

4. Weekly Iron and Folic Acid Supplementation (WIFS)

• For adolescent girls and boys (10-19 years) to combat anaemia
• 100 mg elemental iron + 500 µg folic acid - weekly dose
• Biannual deworming (Albendazole 400 mg)
• Covers 10.25 crore adolescents in rural and urban areas

5. Menstrual Hygiene Scheme

• Free sanitary napkins to adolescent girls in rural areas (subsidized under ASHA/NRHM)
• Kishori Shakti Yojana (KSY) - under Ministry of WCD

6. School Health Programme (under Ayushman Bharat - Health and Wellness Centres)

• Health and wellness sessions in schools
• Life skills education
• Yoga, mental health, first aid

Key health issues addressed:

• Anaemia (prevalence >56% in adolescent girls - NFHS-5)
• Undernutrition and stunting
• Early marriage and pregnancy (<18 years)
• STI/HIV prevention
• Menstrual hygiene
• Substance abuse
• Mental health

4. Health Securities of Elderly in India

Types of Health Securities for the Elderly in India:

A. Constitutional and Legal Provisions:

• Article 41 of Constitution: Right to public assistance in case of old age, sickness, and disablement
• Maintenance and Welfare of Parents and Senior Citizens Act, 2007: Legal right to maintenance from children; tribunals for enforcement; Elderline helpline (14567)

B. National Health Programmes for Elderly:

• Launched under Ministry of Health and Family Welfare
• Objectives:
  • Provide dedicated healthcare facilities for the elderly at various levels
  • Develop trained human resources in geriatric medicine
  • Promote research in elderly healthcare
• Services at different levels:
  • PHC: Dedicated OPD for elderly (weekly), home-based care
  • CHC: Dedicated ward (10 beds), physiotherapy
  • District Hospital: 10-bed geriatric ward, specialist care
  • Regional Geriatric Centres (8 regional institutes): Tertiary care, training
• Home-based care by ANM/ASHA for bedridden elderly

• Provides assistive living devices (walking sticks, wheelchairs, hearing aids, spectacles) to BPL elderly with age-related disabilities
• Free-of-cost through camps organized by ALIMCO

• Health insurance cover up to Rs. 5 lakh per family per year for hospitalization
• Covers elderly from BPL and other eligible families
• Cashless treatment at empanelled hospitals

C. Social Security:

• Indira Gandhi National Old Age Pension Scheme (IGNOAPS): Monthly pension to BPL elderly ≥60 years
  • Rs. 200/month (60-79 years)
  • Rs. 500/month (≥80 years) - Indira Gandhi National Widow/Disability Pension

D. Institutional Care:

• Old Age Homes - under Ministry of Social Justice (Integrated Programme for Senior Citizens - IPSC)
• Day care centres
• Multi-Service Centre for elderly

E. Common Health Problems of Elderly (to be addressed):

• Non-communicable diseases: Hypertension, DM, COPD, CHD, osteoporosis
• Mental health: Depression, dementia, Alzheimer's disease
• Falls and fractures
• Sensory impairment (vision, hearing)
• Polypharmacy and adverse drug reactions
• Urinary incontinence, malnutrition

Q.4 Answer in 2-3 Sentences (Any 5 out of 6) — 5×2=10 marks

1. Mode of Action of Progestogen-Only Contraceptive Pill (Mini-pill)

1. Thickening of cervical mucus - making it hostile to sperm penetration (primary mechanism)
2. Suppression of ovulation (in ~50% of cycles - inconsistent, unlike combined OCP)
3. Endometrial atrophy - making the endometrium unsuitable for implantation
4. Impaired tubal motility - altering the transport of ovum

2. Objectives of School Health Services

1. To assess the health status of school children through periodic health examinations
2. To prevent and control communicable diseases among school children (immunization, screening)
3. To provide early detection and treatment of physical and mental defects
4. To provide health education and inculcate healthy habits in children
5. To provide a healthful school environment (safe water, sanitation, mid-day meals)
6. To promote mental and emotional health of children
7. To serve as a link between school, home, and community for health promotion

3. Define Societal Dependency Ratio

The ratio of the dependent population (children under 15 years + elderly ≥65 years) to the working-age population (15-64 years), expressed per 100.

Dependency Ratio = [(Population <15 years + Population ≥65 years) / Population 15-64 years] × 100

• Child Dependency Ratio = (Population <15 / Population 15-64) × 100
• Old Age Dependency Ratio = (Population ≥65 / Population 15-64) × 100
• India's total dependency ratio: ~47 (2021); declining due to demographic dividend

4. List Any Four Autosomal Dominant Diseases

1. Achondroplasia (dwarfism - FGFR3 gene mutation)
2. Huntington's Disease (progressive neurodegeneration - CAG repeat expansion on chromosome 4)
3. Marfan Syndrome (FBN1 gene - connective tissue disorder)
4. Neurofibromatosis type 1 (NF1) (NF1 gene - café-au-lait spots, neurofibromas)
5. Familial Hypercholesterolaemia (LDLR gene mutation)
6. Polycystic Kidney Disease (ADPKD) (PKD1/PKD2 gene)
7. Myotonic Dystrophy

5. Enumerate Any Four Interventions under Anaemia Mukt Bharat (AMB) Strategy

1. Prophylactic Iron and Folic Acid (IFA) supplementation across life stages (infants, children, adolescents, pregnant women, lactating mothers, women of reproductive age)
2. Biannual deworming for children 1-19 years and pregnant women (Albendazole 400 mg) - reduces iron loss due to parasitic infection
3. Delayed cord clamping (minimum 3 minutes) at birth - increases neonatal iron stores by 40-50%
4. Mandatory fortification of rice with iron/folic acid supplied through PDS, mid-day meal scheme, ICDS
5. Intensive year-round IFA supplementation using platform-based delivery (schools, AWCs, health facilities)
6. Treatment of moderate and severe anaemia at health facilities
7. Behaviour change communication for dietary diversification and adherence to IFA

6. Signs of Possible Serious Bacterial Infection (PSBI) in Infant Less than 2 Months

1. Not feeding well (unable to feed or stopped feeding)
2. Convulsions
3. Drowsiness / Unconsciousness / Difficulty in waking (lethargy)
4. Abnormal movements (twitching)
5. Fast breathing (≥60/min)
6. Severe chest in-drawing
7. Grunting
8. Bulging fontanelle
9. High fever (axillary ≥37.5°C) OR Low body temperature (<35.5°C - hypothermia)
10. Jaundice appearing <24 hours or extending to palms and soles
11. Many or severe skin pustules
12. Umbilicus red or draining pus (omphalitis)
13. Bleeding from injection site or elsewhere